Have Your Voice Heard; Submit Your Abstract Today!

Strategies in Biophotonics is a two-day conference and exhibition that will center on advancing the development and successful commercialization of optics and photonics technologies for the fast-growing biophotonics life sciences market. Papers will be selected by our Advisory Board on the basis of technical content, audience interest and industry relevance. Suggested subject areas and themes are listed below. Mobile Health Global Health Therapy, Diagnostics and/or Screening Oncology Opthamology Neuroscience Drug Development Presentations at Strategies in Biophotonics will ideally address: • A specific NEED (or closely related set of NEEDS) in biomedical research or clinical discipline. - What is the unmet need? - Why is it important? - What technologies are being used currently to serve this area? - What are their limitations? • The OPPORTUNITY for optics and/or photonics to meet this need/these needs - How can optics/photonics address this need? - What value do optics/photonics offer that other technologies do not? • Key CHALLENGE(S) of commercializing a system for this market - Why doesn’t an optics/photonics-based system already exist to meet this need? - What, specifically, must happen in order for an optics/ photonics-based device or system to succeed in this area? • Logical NEXT STEPS for entry into the market - Should the idea be embodied in a new product or a new company Don't wait! Call for Papers Ends Jan 10th, 2014 Please ensure that the speaker and author details you are providing when submitting your abstract are correct as these will be used for pre-event marketing purposes. For information/assistance on submitting an abstract for the Call for Papers, please contact: Karen Gallagher, Conference Manager, 603-891-9304, kareng@pennwell.com • The ONLY event dedicated to enabling product development and market success. • Essential outlet for showcasing the development and commercialization of optics and photonics technologies. • Powered by an outstanding advisory board and program committee led by Barbara Goode, Editor-in-Chief of BioOptics World, and Conard Holton, Editor-in-Chief of Laser Focus World Visitor Profile: • Biomedical Researchers • Bio-optical Engineers • OEMs • Investors • Government Agency Personnel • Clinicians • Regulators Exhibitor Profile: • Optical Component Vendors • Subsystem Suppliers • Bio-optical System Vendors • Optical Design Software Vendors Live FloorplanExhibitor ProspectusExhibitor Listing Exhibitor SearchExhibitor ManualExhibitor Toolkit • Robert R. Alfano, PhD, Distinguished Professor of Science and Engineering and Director of Institute for Ultrafast Spectroscopy and Lasers, City College of the City University of New York • Thomas M. Baer, PhD, Executive Director, Stanford Photonics Research Center; Co-Founder, Arcturus Bioscience, Inc. • Brett Bouma PhD, Professor of Dermatology and Health Sciences and Technology at Harvard Medical School (Cambridge, MA); and Physicist, Wellman Center for Photomedicine, Massachusetts General Hospital. • Robert Chimenti, Sr. Strategic Applications Engineer, Innovative Photonic Solutions • John Dexheimer, President, LightWave Advisors, Inc. • Thomas J. Dudley, Assistant Director, Photonics Center, Boston University • Ken Kaufmann, PhD, VP of Marketing, Hamamatsu Corp. • Dennis L Matthews, PhD, Professor Emeritus, Dept of Neurological Surgery, School of Medicine; Director, NSF Center for Biophotonics Science and Technology; Site Director, Center for Biophotonics Sensors and Systems UC Davis; Chief Scientist, Tahoe Institute for Rural Healthcare Research; Bioscience and Biotechnology Program Development Officer, Lawrence Livermore National Laboratory (LLNL) • Robert J. Nordstrom, PhD, Program Director, Cancer Imaging Program, National Institutes of Health National Cancer Initiative. • Aydogan Ozcan, PhD, Associate Professor, head of Bio- and Nano-Photonics Laboratory, UCLA; Founder, Holomic LLC • Rick Plympton, CEO, Optimax Systems Inc. • Jürgen Popp, PhD, Scientific Director of the Institute of Photonic Technology and chair for Physical Chemistry at the Friedrich-Schiller University Jena • Dale Wahlstrom, President and CEO of LifeScience Alley (LSA) and BioBusiness Alliance of Minnesota.